Functional Assay
Binding of IL-2 Superkine (Fc) (AG-40B-0111) to IL-2Rbeta (human) is increased >10 fold compared to IL-2 (human):Fc (human) . Methods: IL-2Rbeta (human) was coated on an ELISA plate at 1 ug/ml. After blocking and washing steps, indicated concentrations of IL-2 Superkine (Fc) or IL-2 (human):Fc (human) were added. Following incubation for 1 h at RT, the binding was detected using an anti-human Fc antibody (HRP).
Functional Assay
Binding of IL-2 Superkine (Fc) (AG-40B-0111) to IL-2Rbeta (human) is increased >10 fold compared to IL-2 (human):Fc (human) . Methods: IL-2Rbeta (human) was coated on an ELISA plate at 1 ug/ml. After blocking and washing steps, indicated concentrations of IL-2 Superkine (Fc) or IL-2 (human):Fc (human) were added. Following incubation for 1 h at RT, the binding was detected using an anti-human Fc antibody (HRP).
Functional Assay
Binding of IL-2 Superkine (Fc) (AG-40B-0111) to IL-2Rbeta (human) is increased >10 fold compared to IL-2 (human):Fc (human) . Methods: IL-2Rbeta (human) was coated on an ELISA plate at 1 ug/ml. After blocking and washing steps, indicated concentrations of IL-2 Superkine (Fc) or IL-2 (human):Fc (human) were added. Following incubation for 1 h at RT, the binding was detected using an anti-human Fc antibody (HRP).
Functional Assay
Binding of IL-2 Superkine (Fc) (AG-40B-0111) to IL-2Rbeta (human) is increased >10 fold compared to IL-2 (human):Fc (human) . Methods: IL-2Rbeta (human) was coated on an ELISA plate at 1 ug/ml. After blocking and washing steps, indicated concentrations of IL-2 Superkine (Fc) or IL-2 (human):Fc (human) were added. Following incubation for 1 h at RT, the binding was detected using an anti-human Fc antibody (HRP).